Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 22 ... disease in head trauma patients." "We investigated the effects of simvastatin, a 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor, on hippocampal A beta burden in a ...
2009 NOV 2 ... medications that are metabolized via the cytochrome 3A4 and A-SLAVED-LIVER (Amiodarone, Simvastatin, Lovastatin, Atorvastatin, Verapamil, Erythromycin, Diltiazem, cLarithromycin, ...
2009 NOV 2 ... Bologna, Italy report. "All the patients were allocated to treatment with simvastatin 20 mg/day for 2 weeks, then randomly assigned to telmisartan (40-80 mg/day) or ...
2009 NOV 2 ... "This study aimed to describe the clinical experience of the ezetimibe (EZE)/simvastatin (SIMVA) combination in a hypercholesterolaemic Greek population who did not attain the ...
2009 NOV 16 ... "Twenty-eight control subjects without CAD, 27 with CAD and 25 CAD patients under simvastatin treatment were studied. Plasma samples were incubated with a donor nanoemulsion prepared ...
2009 NOV 9 ... study was aimed at probing the effects of intensive cholesterol-lowering therapy with simvastatin on the large artery elasticity of acute myocardial infarction patients. A total of 72 ...
2009 NOV 16 ... A reductase inhibitors) on malaria-associated inflammation in vivo and in vitro. Simvastatin failed to improve survival or alter parasitemia in C57BL/6 mice infected with Plasmodium ...
2009 NOV 16 ... combined low dose statin and gamma-tocotrienol." "Treatment with 8 mc M simvastatin inhibited cell growth and isoprenylation of Rap1A and Rab6, and supplementation with 2 ...
2009 NOV 23 ... investigators in the United States report. "To determine whether simvastatin attenuates airway inflammation and improves lung physiology by mevalonate pathway ...
2009 NOV 23 ... with established therapy." "We investigated the effects of combining simvastatin with a phosphodiesterase type-5 inhibitor, sildenafil, in the rat model of ...
2009 NOV 2 ... inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment' have been presented. "Possible interactions between clopidogrel and ...
2009 NOV 2 ... and organ injury. The aim of the present Study was to examine the effects of simvastatin on endotoxemic liver injury." "Male C57BL/6J mice were challenged ...
2009 NOV 16 ... and the associated neovascularization is not known. Here we determined the effect of simvastatin and the ERK inhibitor, CI1040, on AngII-stimulated AAA formation. ApoE(-/-) mice infused ...
2009 NOV 2 ... treatment of neurons with a low dosage of two CNS-permeable statins (lovastatin and simvastatin) selectively reduced NMDA-induced cell death but not the caspase-mediated apoptosis. The ...
2009 NOV 16 ... subarachnoid hemorrhage (SAH), affects up to 60% of survivors. We hypothesized that oral simvastatin would improve vestibulomotor function and reduce cognitive dysfunction after ...
2009 NOV 2 ... 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol ...
2009 NOV 10 ... ICH was induced in rats," investigators in the United States report. "Simvastatin (2 mg/kg), atorvastatin (2 mg/kg), or phosphate-buffered saline (n = 6 per group) was ...
2009 NOV 2 ... scientists in Pavia, Italy conducted a study "To evaluate the efficacy of fenofibrate, simvastatin or their combination in type 2 diabetic patients with combined dyslipidaemia. and ...
